Protective effects of pycnogenol against ischemia reperfusion-induced oxidative renal injury in rats

Renal Failure

Volumn 31, Issue 8, 2009, Pages 690-697

  Ozer Şehirli, Ahmet ^a   Şener, Göksel ^a   Ercan, Feriha ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

TNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYELOPEROXIDASE; NITROGEN; PYCNOGENOL; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FLAVONOIDS; KIDNEY DISEASES; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 70350653833     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903085971     Document Type: Article

References (59)

1. Gueler F, Gwinner W, Schwarz A, Haller H. Long-term effects of acute ischemia and reperfusion injury, Kidney Int. 2004;66:523-527.
2. Cologna AJ, Lima LV, Tucci S Jr, et al. Cyclosporine action on kidneys of rats submitted to normothermic ischaemia and reperfusion. Acta Cir Bras. 2008;23:36-41.
3. Koo DD, Welsh KI, West NE, et al. Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int. 2001;60:786-796.
4. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74: 1156-1164.
5. Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int. 1993;43:1160-1178.
6. Ishikawa F, Miyazaki S. New biodefense strategies by neutrophils. Arch Immunol Ther Exp (Warsz). 2005;53: 226-233.
7. Kelly KJ, Williams WW, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97:1056-1063.
8. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109:665-678.
9. Yanarates O, Guven A, Sizlan A, et al. Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30:931-938.
10. Amersi F, Nelson SK, Shen XD, et al. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA. 2002;99:8915-8920.
11. Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol. 2002;36:72-77.
12. Mercer LD, Kelly BL, Horne, MK, Beart PM. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem Pharmacol. 2005;69:339-345.
13. Paganga G, Miller N, Rice-Evans CA. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic Res. 1999; 30:153-162.
14. Youdim KA, Joseph JA. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects. Free Radic Biol Med. 2001; 30:583-594.
15. Ansari MA, Keller JN, Scheff SW. Protective effect of pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic Biol Med. 2008; 45:1510-1519.
16. Huang WW, Yang JS, Lin CF, Ho WJ, Lee MR. Pycnogenol induces differentiation and apoptosis in human promyeloid leukemia HL-60 cells. Leuk Res. 2005;29:685-692.
17. Rohdewald P. A review of the French maritime pine bark extract (pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther. 2002;40: 158-168.
18. Matsumori A, Higuchi H, Shimada M. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis. J Cardiac Fail. 2007;13:785-791.
19. Feng WY, Tanaka R, Inagaki Y, et al. Pycnogenol, a procyanidin- rich extract from French maritime pine, inhibits intracellular replication of HIV-1 as well as its binding to host cells. Jpn J Infect Dis. 2008;61:279-285.
20. Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med. 1999;27:704-724. (Pubitemid 29408657)
21. Rohdewald PJ. Pycnogenol, French maritime pine bark extract. In Coates PM, Blackman MR, Cragg GM, Levine M, Moss J, White JD (eds.). Encyclopedia of dietary supplements. New York: Marcel Dekker;2005:545-553.
22. Grimm T, Chovanová Z, Muchová J, et al. Inhibition of NFkappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond). 2006;3:1.
23. Kamuren ZT, McPeek CG, Sanders RA, Watkins JB III. Effects of low-carbohydrate diet and pycnogenol treatment on retinal antioxidant enzymes in normal and diabetic rats. J Ocul Pharmacol Ther. 2006;22:10-18.
24. Ahn TH, Yang YS, Lee JC, et al. Ameliorative effects of pycnogenol on carbon tetrachloride-induced hepatic oxidative damage in rats. Phytother Res. 2007;21:1015-1019.
25. Yang YS, Ahn TH, Lee JC, et al. Protective effects of pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague- Dawley rats. Food Chem Toxicol. 2008;46:380-387.
26. Talke H, Schubert GE. Enzymatic urea determination in the blood and serum in the Warburg optical test. Klin Wochenschr. 1965;43:174-175.
27. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest. 1965; 17: 381-387.
28. Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chim Acta. 1972;40:91-99.
29. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-311.
30. Beutler E. Glutathione in red cell metabolism. In: Beutler E (ed.). A manual of biochemical methods. 2nd ed. New York: Grune & Stratton; 1975;112-114.
31. Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
32. Hillegass LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods. 1990;24:285-295.
33. Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol. 1980;65:105-116.
34. Fiske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375-400.
35. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
36. Kopp EB, Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol. 1995;58:1-27.
37. Park YC, Rimbach G, Saliou C, Valacchi G, Packer L. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaBdependent gene expression in RAW 264.7 macrophages. FEBS Lett. 2000;465:93-97.
38. Kher A, Meldrum KK, Hile KL, et al. Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion. J Thorac Cardiovasc Surg. 2005;130:662-669.
39. Eschwege P, Paradis C, Conti M, et al. In situ detection of lipid peroxidation bproducts as markers of renal ischemia injuries in rat kidneys. J Urol. 1999;162:553-557.
40. Sener G, Sehirli O, Velioglu-Ogünç A, et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res. 2006;54:65-71.
41. Sehirli O, Sener E, Cetinel S, Yüksel M, Gedik N, Sener G. Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol. 2008;35:249-255. (Pubitemid 351257873)
42. Schwacha MG. Macrophages and post-burn immune dysfunction. Burns. 2003;29:1-14.
43. Sibilia V, Rindi G, Pagani F, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: Studies on the mechanisms of action. Endocrinology. 2003;144:353-359.
44. Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3-15.
45. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. J Biomed Sci. 2000; 7:444-458.
46. Laight DW, Lad N, Woodward B, Waterfall JF. Assessment of myeloperoxidase activity in renal tissue after ischemia/ reperfusion. Eur J Pharmacol. 1994;292:81-88.
47. Rodrigo R, Rivera G. Renal damage mediated by oxidative stress: A hypothesis of protective effects of red wine. Free Radic Biol Med. 2002;33:409-422.
48. Li C, Browder W, Kao RL. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. Am J Physiol. 1999;276:H543-H552.
49. Beratni T, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol. 1989;134:419-430.
50. Liebertal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol. 1998;18:505-518.
51. Skou JC, Esmann M. The Na,K-ATPase. J Bioenerg Biomembr. 1992;24:249-261.
52. Kolgazi M, Sener G, Çetinel S, Gedik N, Alican I. Resveratrol reduces renal and lung injury due to sepsis in rats. J Surg Res. 2006;134:315-321.
53. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury, Eur J Pharmacol. 2001;426:1-10. (Pubitemid 32781781)
54. Ilhan N, Halifeoglu I, Ozercan HI, Ilhan N. Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage. Cell Biochem Funct. 2001;19:207-212.
55. Kwon TH, Frokiaer J, Han JS, Knepper MA, Nielsen S. Decreased abundance of major Na+ transporters in kidneys of rats with ischemiainduced acute renal failure. Am J Physiol Renal Physiol. 2000;278:F925-F939.
56. Maritim A, Dene BA, Sanders RA, Watkins JB III. Effects of pycnogenol treatment on oxidative stress in streptozotocininduced diabetic rats. J Biochem Mol Toxicol. 2003; 17:193-199. (Pubitemid 36818195)
57. Siler-Marsiglio KI, Paiva M, Madorsky I, Serrano Y, Neeley A, Heaton MB. Protective mechanisms of pycnogenol in ethanol- insulted cerebellar granule cells. J Neurobiol. 2004;61: 267-276.
58. Mochizuki M, Hasegawa N. Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases. Phytother Res. 2004;18:1027-1028.
59. de Moraes Ramos FM, Schönlau F, Novaes PD, Manzi FR, Bóscolo FN, de Almeida SM. Pycnogenol protects against ionizing radiation as shown in the intestinal mucosa of rats exposed to x-rays. Phytother Res. 2006;20:676-679.